New research shows outcomes are worse for Black patients with acute myeloid leukemia (AML) than white patients who received similar intensive therapy on clinical trials.

Source: https://www.webmd.com/cancer/lymphoma/news/20220707/an-aggressive-leukemia-is-much-more-lethal-for-black-patients-than-whites—why?src=RSS_PUBLIC